Coronavirus Vaccine: Frontrunner Oxford-AstraZeneca vaccine Phase 3 trials to begin in India; vaccine may reach India sooner
Coronavirus Vaccine: Frontrunner Oxford-AstraZeneca vaccine Phase 3 trials to begin in India; vaccine may reach India sooner
IndiaTimes
0 shares
1 views
You might like
Related news coverage
Beijing’s Soft Diplomacy In West Asia In Times Of COVID-19 – Analysis
Eurasia Review
By Nagapushpa Devendra*
The coronavirus disease (COVID-19) that emerged from Wuhan in China in December 2019 has..
-
India readies five sites for final phase of human trials of Oxford COVID vaccine
Mid-Day
-
Coronavirus news bulletin from UAE: Vaccine phase 3 clinical trials begin; cops surprise patients with roses; 105 flights to India under phase 5 of mission
Khaleej Times
-
Adar Poonawalla: I believe Oxford coronavirus vaccine Covishield will reach masses by 2021 first quarter of
Mid-Day
-
COVID-19: Number of recoveries 1.8 times higher than active cases, says Centre
Mid-Day
Advertisement
More coverage
COVID-19 vaccine: Scientists strike note of caution as 'Made in India' vaccine programme gains momentum
New Delhi: India's COVID-19 vaccine programme has gained sudden traction but it is imperative to strike a balance between giving it..
Mid-Day
Q BioMed has a winner in cancer bone pain drug Strontium89 and a deep pipeline of biomedical assets
Acquires undervalued biomedical assets to accelerate their development Developing drugs and therapies to treat pediatric nonverbal..
Proactive Investors